On ECHEMI
Home > Drugs > Tonghua Huikang Biopharmaceutical Co., Ltd.

Tonghua Huikang Biopharmaceutical Co., Ltd.

  • Founded in:

    2011-06-23
  • Country:

    China China
  • Address:

    No. 10, Yongkang Road, Chaoyang Town, Huinan County
  • Tax NO.:

    91220523574085680R
  • Registered Funds:

    80 million yuan
  • Email:

Related Drugs
Insulin injection
The main ingredients of this product are: sterile aqueous solution of insulin (porcine or bovine), which can contain 1.4-1.8g of glycerol and 0.25g of phenol per 100ml.
Name Description Content CAS NO. Registered Holders
Insulin (porcine or bovine)

Inhibits liver glycogenolysis and glycogenoneogenesis, reduces liver output of glucose; promotes liver uptake of glucose and synthesis of liver glycogen; promotes muscle and adipose tissue uptake of glucose and amino acids, promotes the synthesis and storage of protein and fat; causes the liver to produce very low density lipoprotein and activates lipoprotein lipase, promotes the decomposition of very low density lipoprotein; inhibits the decomposition of fat and protein in fat and muscle, inhibits the production of ketone bodies and promotes the utilization of ketone bodies by surrounding tissues.

More

Inhibits liver glycogenolysis and glycogenoneogenesis, reduces liver output of glucose; promotes liver uptake of glucose and synthesis of liver glycogen; promotes muscle and adipose tissue uptake of glucose and amino acids, promotes the synthesis and storage of protein and fat; causes the liver to produce very low density lipoprotein and activates lipoprotein lipase, promotes the decomposition of very low density lipoprotein; inhibits the decomposition of fat and protein in fat and muscle, inhibits the production of ketone bodies and promotes the utilization of ketone bodies by surrounding tissues.

0
Glycerol

This product is a hypoglycemic drug. The main effect of insulin is to lower blood sugar, and it also affects protein and fat metabolism, including the following effects: 1. Inhibit liver glycogenolysis and gluconeogenesis, and reduce liver output of glucose; 2. Promote liver uptake of glucose and synthesis of liver glycogen; 3. Promote muscle and adipose tissue to take up glucose and amino acids, promote protein and fat synthesis and storage; 4. Make the liver produce very low density lipoprotein and activate lipoprotein lipase, promote the decomposition of very low density lipoprotein; 5. Inhibit the decomposition of fat and protein in fat and muscle, inhibit the generation of ketone bodies and promote the use of ketone bodies by surrounding tissues.

More

This product is a hypoglycemic drug. The main effect of insulin is to lower blood sugar, and it also affects protein and fat metabolism, including the following effects: 1. Inhibit liver glycogenolysis and gluconeogenesis, and reduce liver output of glucose; 2. Promote liver uptake of glucose and synthesis of liver glycogen; 3. Promote muscle and adipose tissue to take up glucose and amino acids, promote protein and fat synthesis and storage; 4. Make the liver produce very low density lipoprotein and activate lipoprotein lipase, promote the decomposition of very low density lipoprotein; 5. Inhibit the decomposition of fat and protein in fat and muscle, inhibit the generation of ketone bodies and promote the use of ketone bodies by surrounding tissues.

1.4~1.8g 56-81-5 62
Phenol

This product is a hypoglycemic drug. The main effect of insulin is to lower blood sugar, and it also affects protein and fat metabolism, including the following effects: 1. Inhibit liver glycogenolysis and gluconeogenesis, and reduce liver output of glucose; 2. Promote liver uptake of glucose and synthesis of liver glycogen; 3. Promote muscle and adipose tissue to take up glucose and amino acids, promote protein and fat synthesis and storage; 4. Make the liver produce very low density lipoprotein and activate lipoprotein lipase, promote the decomposition of very low density lipoprotein; 5. Inhibit the decomposition of fat and protein in fat and muscle, inhibit the generation of ketone bodies and promote the use of ketone bodies by surrounding tissues.

More

This product is a hypoglycemic drug. The main effect of insulin is to lower blood sugar, and it also affects protein and fat metabolism, including the following effects: 1. Inhibit liver glycogenolysis and gluconeogenesis, and reduce liver output of glucose; 2. Promote liver uptake of glucose and synthesis of liver glycogen; 3. Promote muscle and adipose tissue to take up glucose and amino acids, promote protein and fat synthesis and storage; 4. Make the liver produce very low density lipoprotein and activate lipoprotein lipase, promote the decomposition of very low density lipoprotein; 5. Inhibit the decomposition of fat and protein in fat and muscle, inhibit the generation of ketone bodies and promote the use of ketone bodies by surrounding tissues.

0.25g 108-95-2 14
Insulin injection
The main ingredients of this product are: sterile aqueous solution of insulin (porcine or bovine), which can contain 1.4-1.8g of glycerol and 0.25g of phenol per 100ml.
Name Description Content CAS NO. Registered Holders
Insulin (porcine or bovine)

Inhibits liver glycogenolysis and glycogenoneogenesis, reduces liver output of glucose; promotes liver uptake of glucose and synthesis of liver glycogen; promotes muscle and adipose tissue uptake of glucose and amino acids, promotes the synthesis and storage of protein and fat; causes the liver to produce very low density lipoprotein and activates lipoprotein lipase, promotes the decomposition of very low density lipoprotein; inhibits the decomposition of fat and protein in fat and muscle, inhibits the production of ketone bodies and promotes the utilization of ketone bodies by surrounding tissues.

More

Inhibits liver glycogenolysis and glycogenoneogenesis, reduces liver output of glucose; promotes liver uptake of glucose and synthesis of liver glycogen; promotes muscle and adipose tissue uptake of glucose and amino acids, promotes the synthesis and storage of protein and fat; causes the liver to produce very low density lipoprotein and activates lipoprotein lipase, promotes the decomposition of very low density lipoprotein; inhibits the decomposition of fat and protein in fat and muscle, inhibits the production of ketone bodies and promotes the utilization of ketone bodies by surrounding tissues.

0
Glycerol

This product is a hypoglycemic drug. The main effect of insulin is to lower blood sugar, and it also affects protein and fat metabolism, including the following effects: 1. Inhibit liver glycogenolysis and gluconeogenesis, and reduce liver output of glucose; 2. Promote liver uptake of glucose and synthesis of liver glycogen; 3. Promote muscle and adipose tissue to take up glucose and amino acids, promote protein and fat synthesis and storage; 4. Make the liver produce very low density lipoprotein and activate lipoprotein lipase, promote the decomposition of very low density lipoprotein; 5. Inhibit the decomposition of fat and protein in fat and muscle, inhibit the generation of ketone bodies and promote the use of ketone bodies by surrounding tissues.

More

This product is a hypoglycemic drug. The main effect of insulin is to lower blood sugar, and it also affects protein and fat metabolism, including the following effects: 1. Inhibit liver glycogenolysis and gluconeogenesis, and reduce liver output of glucose; 2. Promote liver uptake of glucose and synthesis of liver glycogen; 3. Promote muscle and adipose tissue to take up glucose and amino acids, promote protein and fat synthesis and storage; 4. Make the liver produce very low density lipoprotein and activate lipoprotein lipase, promote the decomposition of very low density lipoprotein; 5. Inhibit the decomposition of fat and protein in fat and muscle, inhibit the generation of ketone bodies and promote the use of ketone bodies by surrounding tissues.

1.4~1.8g 56-81-5 62
Phenol

This product is a hypoglycemic drug. The main effect of insulin is to lower blood sugar, and it also affects protein and fat metabolism, including the following effects: 1. Inhibit liver glycogenolysis and gluconeogenesis, and reduce liver output of glucose; 2. Promote liver uptake of glucose and synthesis of liver glycogen; 3. Promote muscle and adipose tissue to take up glucose and amino acids, promote protein and fat synthesis and storage; 4. Make the liver produce very low density lipoprotein and activate lipoprotein lipase, promote the decomposition of very low density lipoprotein; 5. Inhibit the decomposition of fat and protein in fat and muscle, inhibit the generation of ketone bodies and promote the use of ketone bodies by surrounding tissues.

More

This product is a hypoglycemic drug. The main effect of insulin is to lower blood sugar, and it also affects protein and fat metabolism, including the following effects: 1. Inhibit liver glycogenolysis and gluconeogenesis, and reduce liver output of glucose; 2. Promote liver uptake of glucose and synthesis of liver glycogen; 3. Promote muscle and adipose tissue to take up glucose and amino acids, promote protein and fat synthesis and storage; 4. Make the liver produce very low density lipoprotein and activate lipoprotein lipase, promote the decomposition of very low density lipoprotein; 5. Inhibit the decomposition of fat and protein in fat and muscle, inhibit the generation of ketone bodies and promote the use of ketone bodies by surrounding tissues.

0.25g 108-95-2 14
Oxymatrine for injection
The main ingredient of this product is matrine, and its chemical name is: oxymatrine.
Name Description Content CAS NO. Registered Holders
Ammothamnine

It can reduce the level of DHBV-DNA in the serum of ducks infected with hepatitis B virus (DHBV) and has a protective effect on toxic liver damage in mice caused by CCL4 and galactosamine

More

It can reduce the level of DHBV-DNA in the serum of ducks infected with hepatitis B virus (DHBV) and has a protective effect on toxic liver damage in mice caused by CCL4 and galactosamine

16837-52-8 11
Osseous peptide injection
It includes organic calcium, phosphorus, inorganic calcium, inorganic salts, trace elements, amino acids, etc.
Name Description Content CAS NO. Registered Holders
Organic Calcium Boron Zinc

Regulate bone metabolism, promote new bone formation, increase bone calcium deposition, and prevent and treat osteoporosis

More

Regulate bone metabolism, promote new bone formation, increase bone calcium deposition, and prevent and treat osteoporosis

0
Phosphorus

Regulate calcium and phosphorus metabolism, prevent and treat osteoporosis

More

Regulate calcium and phosphorus metabolism, prevent and treat osteoporosis

7723-14-0 0
Inorganic perovskite quantum dots CSPBX3 (X is CL, BR, I halogen)

Regulate bone metabolism, increase bone calcium deposition, and prevent osteoporosis

More

Regulate bone metabolism, increase bone calcium deposition, and prevent osteoporosis

0
Inorganic salt

This product contains a variety of active peptides for bone metabolism, which can regulate bone metabolism, stimulate osteoblast proliferation, promote new bone formation, regulate calcium and phosphorus metabolism, increase bone calcium deposition, prevent and treat osteoporosis, and have anti-inflammatory and analgesic effects.

More

This product contains a variety of active peptides for bone metabolism, which can regulate bone metabolism, stimulate osteoblast proliferation, promote new bone formation, regulate calcium and phosphorus metabolism, increase bone calcium deposition, prevent and treat osteoporosis, and have anti-inflammatory and analgesic effects.

0
Trace Elements

This product contains a variety of active peptides for bone metabolism, which can regulate bone metabolism, stimulate osteoblast proliferation, promote new bone formation, regulate calcium and phosphorus metabolism, increase bone calcium deposition, prevent and treat osteoporosis, and have anti-inflammatory and analgesic effects.

More

This product contains a variety of active peptides for bone metabolism, which can regulate bone metabolism, stimulate osteoblast proliferation, promote new bone formation, regulate calcium and phosphorus metabolism, increase bone calcium deposition, prevent and treat osteoporosis, and have anti-inflammatory and analgesic effects.

0
L-tert-Leucine

This product contains a variety of active peptides for bone metabolism, which can regulate bone metabolism, stimulate osteoblast proliferation, promote new bone formation, regulate calcium and phosphorus metabolism, increase bone calcium deposition, prevent and treat osteoporosis, and have anti-inflammatory and analgesic effects.

More

This product contains a variety of active peptides for bone metabolism, which can regulate bone metabolism, stimulate osteoblast proliferation, promote new bone formation, regulate calcium and phosphorus metabolism, increase bone calcium deposition, prevent and treat osteoporosis, and have anti-inflammatory and analgesic effects.

20859-02-3 0
Active peptides for bone metabolism

Regulate bone metabolism, stimulate osteoblast proliferation, promote new bone formation, regulate calcium and phosphorus metabolism, increase bone calcium deposition, prevent and treat osteoporosis, anti-inflammatory, analgesic

More

Regulate bone metabolism, stimulate osteoblast proliferation, promote new bone formation, regulate calcium and phosphorus metabolism, increase bone calcium deposition, prevent and treat osteoporosis, anti-inflammatory, analgesic

0
Alprostadil for injection
Chemical name: (1R, 2R, 3R)-3-hydroxy-2[(E)-(3S)-3-hydroxy-1-octenyl]-5-oxocyclopentaneheptanoic acid
Name Description Content CAS NO. Registered Holders
Prostaglandin E1

The intravenous alprostadil preparation with lipid microspheres as drug carriers is not easy to inactivate alprostadil due to the encapsulation of lipid microspheres. It has the targeted property of being easily distributed to damaged blood vessels, thereby playing the role of dilating blood vessels and inhibiting platelet aggregation.

More

The intravenous alprostadil preparation with lipid microspheres as drug carriers is not easy to inactivate alprostadil due to the encapsulation of lipid microspheres. It has the targeted property of being easily distributed to damaged blood vessels, thereby playing the role of dilating blood vessels and inhibiting platelet aggregation.

745-65-3 14
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.